The global green hydrogen market was valued at $227.7 million in 2021 and is projected to reach $108.64 billion by 2031, registering a CAGR of 68.9% between 2022 and 2031 in terms of value.

Green hydrogen is a hydrogen-produced fuel obtained from the electrolysis of water with electricity generated by renewable energy sources. Hydrogen is one of the prominent energy carriers that can be used in different applications, such as oil and gas, industrial feedstock, mobility, and power generation.

Various countries and regions, including Europe, the U.K., China, South Korea, Japan, Canada, South Africa, and the U.S., have adopted net zero objectives. These developments of national and international “net zero” objectives has been one of the most noteworthy characteristics of climate policy in recent years.

Renewables and batteries can help to decarbonize power generation and the automobile industry. Heating may also be decarbonized in some areas by using heat pumps driven by renewable energy.

Market Lifecycle Stage

The green hydrogen market has been developing significantly since early 2000, and much has been attributed to the technological advancements in this field. The ecosystem of the green hydrogen market comprises technology suppliers, green hydrogen producers, and end users. The market is still developing, with Europe at the forefront, followed by other regions such as North America, Asia-Pacific, the U.K., China, and Rest-of-the-World.

Industrial Impact

• Green hydrogen is one of the gases with an increase in demand from the petroleum refining industry due to its function in different refining processes such as hydrocracking, hydroisomerization, hydrodealkylation, and hydrodesulfurization, and it has a high impact on the oil and gas sector.

• Furthermore, green hydrogen has a moderate to high impact on the industrial feedstock sector, as green hydrogen is used in the production of ammonia, methanol, steel, and other industrial products.

Impact of COVID-19

The COVID-19 pandemic considerably impacted the production of green hydrogen because of country-wide shutdowns of manufacturing sites, labor shortages, and disruptions in supply and demand chains globally, which distorted the market. The supply of green hydrogen declined in industrial sectors such as industrial feedstock and oil and gas.

Amid the pandemic, major announced projects got delayed; however, they are expected to gain traction with economic recovery during the post-pandemic period.

Market Segmentation:

Segmentation 1: by Application

• Oil and Gas
• Industrial Feedstock
o Ammonia
o Methanol
o Steel
o Others
• Mobility
• Power Generation
• Others

Oil and gas is anticipated to be one of the prominent end-use markets for green hydrogen during the forecast period 2022-2031.

Segmentation 2: by Technology

• Proton Exchange Membrane (PEM) Electrolyzer
• Alkaline Electrolyzer
• Anion Exchange Membrane
• Solid Oxide Electrolyzer

Based on technology, the green hydrogen market is estimated to be led by alkaline electrolyzer during the forecast period, 2022-2031.

Segmentation 3: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Italy, Spain, Russia, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Rest-of-the-World

In the global green hydrogen market, Europe and North America are anticipated to gain traction in terms of green hydrogen production, owing to the continuous growth in the oil and gas industry and the presence of the world’s largest manufacturers in those regions.

Recent Developments in Green Hydrogen Market

• In August 2022, Linde inaugurated the world’s first hydrogen refuelling system for passenger trains in Bremervorde, Germany. The company’s hydrogen refuelling system has been designed and constructed with the ability to integrate future on-site green hydrogen generation.
• In March 2022, Air Liquide received support from the French State, subject to final validation by the European Commission, to launch its Air Liquide Normand’Hy large-scale renewable hydrogen production project. This electrolyzer of an initial 200 MW capacity, which should notably provide renewable hydrogen to TotalEnergies’ Normandy refinery and will use Siemens Energy technology.
• In November 2022, Air Products and Associated British Ports (ABP) partnered to bring the first large-scale, green hydrogen production facility to the U.K. The facility would import green ammonia from production locations operated by Air Products and its partners around the world. This would be used to produce green hydrogen, which would decarbonize hard-to-abate sectors such as transport and industry.

Demand – Drivers and Limitations

Following are the demand drivers for the green hydrogen market:

• Increasing Awareness Regarding Green Hydrogen
• Low Variable Renewable Energy (VRE) Electricity Cost

The market is expected to face some limitations due to the following challenges:

• High Cost of Production
• Limited Dedicated Transport Infrastructure

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different technologies involved in the green hydrogen market. The technology segment includes a proton exchange membrane electrolyzer, alkaline electrolyzer, anion exchange membrane, and solid oxide electrolyzer. Moreover, the study provides the reader with a detailed understanding of the green hydrogen market based on application, including oil and gas, industrial feedstock, mobility, power generation, and others. The government imposing stringent regulations related to carbon emissions is fuelling the demand for green hydrogen.

Growth/Marketing Strategy: The green hydrogen market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, mergers and acquisitions, and joint ventures. The favored strategy for the companies has been business partnership and collaboration to strengthen their position in the green hydrogen market. For instance, in July 2019, Linde and Beijing Green Hydrogen Technology Development Co., Ltd. signed a memorandum of understanding (MoU). The businesses are collaborating on several green hydrogen initiatives, including hydrogen technology research and development and the deployment of green hydrogen transportation solutions for China’s inaugural hosting of the Winter Olympics in 2022.

Competitive Strategy: Key players in the green hydrogen market analyzed and profiled in the study involve green hydrogen manufacturers and the overall ecosystem. Moreover, a detailed competitive benchmarking of the players operating in the green hydrogen market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Green hydrogen is mainly being utilized in the oil & gas, and mobility industry. At present, hydrogen production mainly relies on natural gas and coal, accounting for 99 percent of production. Electrolysis produces approximately 1 percent of global hydrogen. At present, renewable energy does not produce a large amount of hydrogen, and green hydrogen is mostly limited to demonstration projects.

Key Companies Profiled

• Linde
• Air Liquide
• Air Products Inc.
• ENGIE
• Uniper SE
• Siemens Energy
• Green Hydrogen
• Cummins Inc.
• Toshiba Energy Systems & Solutions Corporation
• Nel ASA
• SGH2 Energy Global, LLC
• PLUG POWER INC.
• Aker Horizons
• HY2GEN AG
• Fusion-Fuel

The post Green Hydrogen Market – A Global and Regional Analysis: Focus on Application, Technology – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is expected to be driven by high investments in the field of cancer research and the rising prevalence of prostate cancer in U.S. In addition, the focus of business leaders is establishing a deep understanding to address the unmet needs in clinical research to understand the prostate cancer market.

Market Lifecycle Stage

The U.S. prostate cancer testing market is in progressing phase. PSA screening or testing in a general population has increased the incidence of prostate cancer in recent decades. In addition, prostate cancer testing is essential in precision medicine because it assures the safe and successful use of tailored therapies. The majority of the companies in the U.S. prostate cancer testing market provide biomarker tests that are urine, blood, and tissue-based, as well as testing services. Furthermore, applications of prostate cancer testing are primarily clinical and research.

Impact

One of the main reasons for the expansion of the prostate cancer testing market in the upcoming years is the rise in prostate cancer cases. Prostate cancer is the second most frequent disease diagnosed in men, and its frequency is rising across the globe. Prostate cancer is thought to be diagnosed in one million additional cases worldwide each year. Due to an aging population, growing urbanization, and accompanying lifestyle changes, the overall incidence of prostate cancer has increased over the past few decades.

Impact of COVID-19

During the coronavirus disease 2019 (COVID-19) pandemic, a number of disease models issued warnings about an excess of cancer fatalities brought on by missed cancer screenings as a result of the general population’s quarantine and a lack of healthcare resources. The COVID-19 pandemic has had a negative impact on early diagnosis in the specific case of prostate cancer, the second most common cancer in men, by reducing participation in screening programs and on time from diagnostic testing to surgery/radiotherapy, which may translate into a worse prostate-cancer-specific death rate in the coming years. Additionally, in other areas, including Florida, state governments disallowed non-essential healthcare services.

Significant reductions in cancer screenings were seen in the early stages of the COVID-19 pandemic. According to a research paper published in January 2022 by the University of Florida, screenings for prostate cancer were reduced by 74%. Due to these screening figures, there may have been thousands more cancer deaths in the U.S. than were registered.

For instance, prostate-specific antigen (PSA) testing rates and the identification of several urological malignancies, including prostate cancer, have been found to be declining in significantly afflicted populations. Several Australian urologists worry that men with possibly curable prostate cancer may have missed their chance for a cure due to low screening test uptake during the lockdowns of 2020. According to a research paper published by BMC Urology in June 2022, a total of 4,048,099 PSA tests and 118,328 prostate biopsies were performed in Australia over the six years of data analysis. In the years 2019 and 2020, 68,429 prostate magnetic resonance imaging (MRI) were performed. Between 2015 and 2019, there were, on average, 19,573 prostate biopsies and 678,082 PSA testing performed per year.

Market Segmentation:

Segmentation 1: by Biomarker Type

• Initial Evaluation: Prostate-Specific Antigen (Total PSA, Free PSA)
• Pre-Biopsy/Post-Negative Biopsy Testing
• Post-Biopsy Tissue Testing

Based on biomarker type, the pre-biopsy test in the U.S. prostate cancer testing market is expected to be dominated by the biomarker type segment. This is due to the increasing popularity of prostate cancer testing and rising awareness related to prostate cancer testing.

Segmentation 2: by Application

• Diagnostics Biomarkers
• Prognostics Biomarkers

Based on application, the U.S. prostate cancer testing market is dominated by the diagnostics biomarkers segment owing to the rising R&D activity focused on the development of prostate cancer testing. The diagnosis of prostate cancer has developed a new molecular-based diagnostics technology. To detect clinically relevant cancer upon diagnosis, several tools or therapeutic options are required to improve the patient’s quality of life.

Segmentation 3: by End User

• Cancer Research Institutes
• Diagnostic Laboratories
• Hospitals and Clinics
• Ambulatory Surgical Center (ASCs)
• Others

As of 2021, the U.S. prostate cancer testing market (by end user) was dominated by ambulatory surgical centers (ASCs), holding a 28.55% market share with a market value of $155.3 million.

Segmentation 4: by Region

• Northeast U.S.
• Midwest U.S
• South U.S.
• West U.S.

The TAM of the pre-biopsy/post-negative biopsy testing segment is expected to grow at a CAGR of 4.5% during the forecast period 2022-2030 in the South U.S. prostate cancer testing market. Several established diagnostics manufacturers in this region who are focusing on expanding their portfolios in prostate cancer testing and are collaborating with service providers and pharmaceutical giants to co-market prostate cancer testing solutions with its complementary precision medicine solutions. Moreover, the U.S. government is currently undertaking several initiatives to develop tests for cancer and provide funds to new start-ups in the cancer diagnostics field.

Recent Developments in the U.S. Prostate Cancer Testing Market

• In September 2022, Veracyte, Inc. announced the publishing of data in the Journal of the National Cancer Institute to demonstrate the company’s decipher prostate genomic classifier may help identify African American men with early, localized prostate cancer who are most likely to harbor more aggressive disease.
• In August 2019, BioReference Laboratories, Inc. announced the selection by The IPA Association of America (TIPAAA) as its provider of laboratory services and to assist with data analytics for its members’ patients. The agreement is designed to enhance patient care and offers collaborative health management tools to TIPAAA members, which includes more than 667 medical organizations in 39 states. The members can have convenient access to BioReference’s comprehensive laboratory testing menu, including routine and specialty tests, as well as the 4Kscore for detecting aggressive prostate cancer.
• In June 2021, Thermo Fisher Scientific announced submissions open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. The grant aims to provide funding for high-quality molecular profiling studies focusing on the impact of immune-based treatments for cancer patients.

Demand – Drivers and Limitations

The following are the demand drivers for the U.S. prostate cancer testing market:

• Rising Prevalence of Prostate Cancer in the U.S.
• Increasing Number of Prostate Cancer Screening and Testing
• Government Initiatives Related to Prostate Cancer

The market is expected to face some limitations due to the following challenges:

• High Probability of False Positives during Prostate Cancer Testing
• Clinical Gaps Related to Prostate Cancer Testing

How can this report add value to an organization?

Workflow/Innovation Strategy: The workflow segment helps the reader understand the two prostate cancer testing, i.e., initial evaluation: prostate-specific antigen (total PSA, free PSA), pre-biopsy/post-negative biopsy testing, post-biopsy tissue testing, which further aid in diagnosis. Moreover, the study provides the reader with a detailed understanding of the different applications of prostate cancer testing in clinical and research applications.

Growth/Marketing Strategy: Prostate cancer testing is being used for both research and clinical application. Various companies are providing urine and blood, and tissue-based biomarkers that aid in the diagnosis, which is also the key strategy for market players to excel in the current prostate cancer testing market.

Competitive Strategy: Key players in the U.S. prostate cancer testing market are analyzed and profiled in the study, including manufacturers who are involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the U.S. prostate cancer testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled:

• Abbott.
• Abcam plc.
• Agilent Technologies, Inc.
• Bio-Techne. (ExoDx)
• Cleveland Diagnostics, Inc.
• Danaher. (Beckman Coulter, Inc.)
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd (FOUNDATION MEDICINE, INC.)
• H.U. Group Holdings, Inc. (Fujeribio)
• mdxhealth.
• Siemens Healthcare GmbH
• Myriad Genetics, Inc.
• NeoGenomics Laboratories.
• OPKO Health, Inc. (GenPath)
• Veracyte, Inc.

The post U.S. Prostate Cancer Testing Market – A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region – Analysis and Forecast, 2022-2030 first appeared on CRI Report.

The U.S. women health laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030. The market is driven by factors such as the increase in the prevalence of infectious diseases and cancer in women, rising awareness regarding women health-related tests, the rising average maternal age leading to increased risk of fetal chromosomal aneuploidies, and the upsurge in reproductive health problems leading to increased demand for laboratory testing in women.

Market Lifecycle Stage

The U.S. women health laboratory testing market is in the developed phase. The advancements in diagnostic technologies including applications of genetic testing in women’s health and the significant number of mergers and acquisitions of companies to attain a better market share are some of the major opportunities in the U.S. women health laboratory testing market.

Market Segmentation:

Segmentation 1: by Hereditary Cancer

• Breast Cancer
• Cervical Cancer
• Ovarian Cancer

The U.S. women health laboratory testing market (hereditary cancer) is expected to be dominated by the cervical cancer segment.

Segmentation 2: by Prenatal Screening and Diagnostic Testing

• Non-Invasive Prenatal Testing (NIPT)
• Maternal Serum Screening (MSS)
• Prenatal Diagnostic Testing

The U.S. women health laboratory testing market (prenatal screening and diagnostic testing) is dominated by the non-invasive prenatal testing segment.

Segmentation 3: by Reproductive Health and Infectious Diseases

• Pregnancy and Ovulation Testing
• HPV Testing
• PAP Smear Testing
• HIV Testing
• CT/NG Testing
• Preimplantation Genetic Testing (PGT)
• Sexually Transmitted Infections
• Herpes Simplex Virus (HSV)
• Hepatitis
• Vaginal Infections

The U.S. women health laboratory testing market (reproductive health and infectious diseases) is dominated by the HIV testing segment.

Segmentation 4: by Region

• Northeast Region
• Midwest Region
• South Region
• West Region

The U.S. women health laboratory testing market (by region) is dominated by the South region segment.

Recent Developments in the U.S. Women Health Laboratory Testing Market

• In November 2022, Roche Holdings launched its Cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S. The system can assist in the diagnosis of Infectious diseases, such as HIV, Hepatitis, transplant-associated viral illnesses, and respiratory and STIs.
• In February 2022, the Laboratory Corporation of America Holdings established a strategic partnership with Ascension to expand its testing capabilities.
• In January 2022, Yourgene announced that it has signed a strategic partnership agreement with EKF Diagnostics Holdings plc a point-of-care business with accredited laboratory testing capabilities in the U.S.
• In November 2022, Myriad Genetics announced that it has acquired Gateway Genomics, LLC, a personal genomics company and developer of consumer genetic tests.
• In August 2022, Natera, Inc. announced that the company has proactively filed a pre-submission to the FDA for its Panorama non-invasive prenatal test (NIPT) as part of the Q-Sub process.
• In August 2021, the Laboratory Corporation of America Holdings acquired Ovia Health, to extend its leadership in women’s health.
• In August 2021, Myriad Genetics expanded access to genetic testing by launching a new version of its market-leading MyRisk Hereditary Cancer Test

Demand – Drivers and Limitations

The following are the drivers for the U.S. Women Health Laboratory Testing Market:

• Increase in the Prevalence of Infectious Diseases and Cancer in Women Leads to Increased Demand for Diagnosis
• Rising Awareness Regarding Women Health-Related Tests
• Rising Average Maternal Age Leading to Increasing Risk of Fetal Chromosomal Aneuploidies
• Upsurge in Reproductive Health Problems Leads to Increased Demand for Laboratory Testing in Women

The market is expected to face some limitations as well due to the following challenges:

• Stringent Regulatory Guidelines Related to Laboratory Testing Hindering the Market Growth in the U.S.
• Disparity in Awareness of Pregnancy and Fertility Issues in the Different Regions of the U.S.

How can this report add value to an organization?

Segments: The different segment of the report helps the reader understand the different type of laboratory tests/services for women’s health available in the market. Moreover, the study provides the reader with a detailed understanding of tests/services that fall under the different segments, which are hereditary cancer, carrier screening, prenatal screening, and diagnostic testing, reproductive health and infectious diseases, and obstetrics and gynecology.

Growth/Marketing Strategy: The U.S. women health laboratory testing market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, merger and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been regulatory and legal activities to strengthen the position of their product in the U.S. market. For instance, in October 2019, Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved myChoice CDx for use as a companion diagnostic for Treatment with Zejula in Late-line Ovarian Cancer.

The post U.S. Women Health Laboratory Testing Market – A Region-Wise Analysis: Focus on U.S. Women Health Laboratory Testing Market – Analysis and Forecast, 2022-2030 first appeared on CRI Report.

In terms of value, the evolving deep space technologies market was valued at $7,509.0 million in 2021 and is projected to be valued at $1,039.3 million by 2032. Evolving deep space technologies market is expected to be driven by an increase in the number of missions, emergence of public and private space industries, huge technological investment, and funding by the government space agencies, among other factors.

Market Lifecycle Stage

Evolving deep space technologies have gained significant importance between 2019-2022. The space industry is continuously innovating and developing advanced technologies with the objective of increasing the demand for deep space exploration. Over the past few years, the development of advanced technologies and other operational techniques, including reusable launch vehicles, sustainable technologies, human and robotic servicing, and autonomous space operations, has been accelerated due to the integration of these technologies with deep learning and artificial intelligence (AI) capabilities. The evolution in deep space navigation and guidance techniques and the development of artificial intelligence (AI) technologies are driving the evolving deep space technologies market growth across sectors.

Impact

Deep space exploration has reached great advancement in a variety of fields, including those related to energy and the environment, consumer products, transportation, consumer services, information technology, and industrial uses. The major challenge in developing deep space technologies is that the cost associated with the manufacturing of space platforms and components is very high. The numerous levels of research, evaluation, testing, reviews, and documentation according to the set standards at each stage of manufacturing system components are expensive and time-consuming. Additionally, insufficient power backup for deep space missions is another challenge. Moreover, deep space missions are not recurring every year. This results in the declining demand of the evolving deep space technologies market.

Market Segmentation

Segmentation 1: by Application

• Moon Exploration
• Mars Exploration
• Asteroid Exploration
• Other (Planetary Exploration)

Based on application, evolving deep space technologies market is expected to be dominated by the other planetary exploration segment.

Segmentation 2: by End User

• Commercial
• Government

Based on end user, evolving deep space technologies market is expected to be dominated by the government segment.

Segmentation 3: by Technology

• Launch Vehicles
• Landers
• Orbiters
• Robotic Rovers
• Space Probes

Based on technology type, the evolving deep space technologies market is expected to be dominated by orbiter segment during the forecast period.

Segmentation 4: by Mission

• Crewed Mission
• Uncrewed Mission

Segmentation 5: by Region
• North America – U.S. and Canada
• Europe – France, Germany, U.K., and Rest-of-Europe
• Asia-Pacific – China, Japan, India, and Rest-of-Asia-Pacific
• Rest-of-the-World – Middle East and Africa, and South America

North America accounted for a higher share because the maximum number of companies are present in the region, along with the large contribution of the U.S. government toward the space budget, which helps in developing and enhancing the region’s space sector in terms of deep space explorations.

Recent Developments in the Evolving Deep Space Technologies Market

• On 22 November 2022, ispace inc., an aerospace company developing robotic spacecraft technologies, launched its lunar landing mission, named Hakuto-R Mission1. This mission carried commercial and government payloads, including two lunar rovers, Rashid, and the Japanese Lunar Excursion Vehicle.
• In August 2022, The NASA Small Business Innovation Research (SBIR) Sequential Phase II program selected Astrobotic to develop, test, and fly lunar night survival and communication technologies onboard its Cube Rover platform.
• On 28 June 2022, Rocket Lab, a leading launch and space systems company, launched NASA’s Cislunar Autonomous Positioning System Technology Operations and Navigation Experiment (CAPSTONE) spacecraft. This mission aims to verify the orbital stability of a Near Rectilinear Halo Orbit around the Moon, which is the same orbit planned for Gateway.
• In May 2022, The European Space Agency (ESA) awarded a contract worth $490 million to Airbus to further develop and build LISA Pathfinder. Now the mission is in phase B1, and all technological advancements are planned to be completed by 2024.
• In April 2022, Northrop Grumman Corporation partnered with the National Aeronautics and Space Administration (NASA) for the development of the James Webb Space Telescope.
• In April 2022, Firefly Aerospace completed Integration Readiness Review (IRR) of its Blue Ghost Lunar Lander. IRR test was completed just after six months of Critical Design Review (CDR).
• On 15 February 2022, Lockheed Martin Corporation received three contracts worth $ 231.6 million from the National Aeronautics and Space Administration (NASA) for the visionary Mars Sample Return program and for building the space rocket named Mars Ascent Vehicle (MAV).
• On 10 February 2022, GITAI, a space robotics start-up, announced the development of its advanced lunar robotic rover, “R1” that can perform general-purpose tasks on the Moon such as exploration, mining, inspection, maintenance, and assembly.

Demand – Drivers and Limitations

Following are the drivers for evolving deep space technologies market:

• Increasing Efforts for Deep Space Exploration Missions by Government and Commercial Entities
• Utilization of Artificial Intelligence (AI) and Robotics in Space Technologies

Following are the challenges for evolving deep space technologies market:

• Insufficient Power Backup for Deep Space Missions
• High Cost Associated with Deep Space Technology Components

Following are the opportunities for evolving deep space technologies market:

• Entrance of Non-Space Participants into the Space Industry
• In-Situ Resource Utilization for Further Deep Space Exploration

How can this report add value to an organization?

Platform/Innovation Strategy: The product segment helps the reader to understand the different types of evolving deep space technologies in the industry to conduct planetary explorations as well as human spaceflight and habitation explorations. Moreover, the study provides the reader with a detailed understanding of the different deep-space technologies such as orbiters, landers, robotic rovers, space drones, and launch vehicles.

Growth/Marketing Strategy: Evolving deep space technologies market has seen major development activities by key players operating in the market, such as business expansion activities, contracts, mergers, partnerships, collaborations, and joint ventures. The favored strategy for the companies has been contracts to strengthen their position in evolving deep space technologies market. For instance, on 19 April 2022, the European Space Agency (ESA) awarded a contract worth $490 million to Airbus to further develop and build LISA Pathfinder. Now the mission is in phase B1, and all technological advancements are planned to be completed by 2024. Furthermore, in September 2022, Axiom Space was awarded a $228 million contract to develop space suits for the Artemis-3 mission.

Competitive Strategy: Key players in evolving deep space technologies market analyzed and profiled in the study involve deep space technologies manufacturers that offer orbiters, landers, rovers, and space probes technologies to explore the planets. Moreover, a detailed competitive benchmarking of the players operating in evolving deep space technologies market offers advanced technologies such as surface habitat module and airlock module that generates new possibilities for robotic scientific missions. Additionally, comprehensive competitive strategies such as contracts, partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysis of the company’s market coverage, product portfolio, and market penetration.

In 2021, the top segment players leading the market included established players, constituting 54% of the presence in the market. Emerging market participants include start-up entities that account for approximately 46% of the presence in the market.

Key Companies Profiled

• Lockheed Martin Corporation
• Northrop Grumman Corporation
• Thales Alenia Space
• Boeing
• Airbus
• Astrobotic Technology
• Maxar Technologies
• Firefly Aerospace
• Intuitive Machines
• Redwire Corporation
• GITAI
• Lunar Outpost
• ispace
• Mu Space
• Axiom Space

The post Evolving Deep Space Technologies Market – A Global and Regional Analysis: Focus on Application, Mission, End User, Technology, and Country Analysis – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.

The market is driven by factors such as the low cost of sequencing platforms, increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling, a tremendous rise in the amount of genomic data, the growing importance of population genomics studies and the establishment of various biobanks, advancements in big data technology, and government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.

Market Lifecycle Stage

The global NGS informatics market is in the development phase. The evolving regulatory landscape for clinical NGS and the growing number of gene mutations across various diseases are some of the major opportunities in the global NGS informatics market.

Impact of COVID-19

NGS can be used to sequence genomes of unknown organisms, owing to which it was extensively performed in research laboratories during the COVID-19 pandemic. Research using NGS sequencing has been carried out in several countries globally, including countries in emerging regions such as Latin America and Middle East and Africa.

Initiatives such as the “SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES)” program by the Centers for Disease Control and Prevention (CDC) were also undertaken to promote the sequencing of the SARS-CoV-2 virus using NGS techniques. Furthermore, the emergence of the COVID-19 pandemic broadened the applications of NGS.

As a result, companies also developed NGS solutions for the genomic surveillance of the SARS-CoV-2 virus. Before the COVID-19 pandemic, NGS technology was particularly employed for the clinical diagnosis of cancers and other chronic diseases. The onset of the COVID-19 pandemic accelerated research in the use of NGS for sequencing the unknown variants of the SARS-CoV-2 virus.

Market Segmentation:

Segmentation 1: by Products and Services

• Commercial Data Analysis, Data Interpretation, and Reporting Tools
• Storage and Computing Tools
• Laboratory Information Management Systems (LIMS)
• NGS Informatics Services

The global NGS informatics market (by products and services) is expected to be dominated by the commercial data analysis tools, interpretation, and reporting tools segment.

Segmentation 2: by Application

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

The global NGS informatics market (by application) is expected to be dominated by the genetic screening segment.

Segmentation 3: by End User

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

The global NGS informatics market (by end user) is dominated by the pharmaceutical and biotechnology companies segment.

Segmentation 4: by Region

• North America – U.S. and Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

The global NGS informatics market (by region) is dominated by the North America region.

Recent Developments in the Global NGS Informatics Market

• In August 2022, Thermo Fisher Scientific Inc. launched CE-IVD (IVDD) NGS test and analysis software to expand access to precision oncology bio-market testing.
• In June 2022, Thermo Fisher Scientific received CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflow.
• In April 2021, Agilent acquired Resolution Bioscience to expand its role in the NGS market for precision oncology.
• In June 2020, Illumina acquired BlueBee to accelerate the processing, analysis, and sharing of NGS data at scale. The integration of BlueBee’s capabilities into Illumina’s cloud portfolio would give users the flexibility to run their own custom analyses or access industry-leading options such as the DRAGEN Bio-IT Platform, streamlining data processing and increasing their operational efficiency.
• In July 2021, Francisco Partners signed a definitive agreement to acquire the STARLIMS informatics product suite and related businesses.
• In April 2021, Illumina Inc. and Kartos Therapeutics entered into a partnership to co-develop an NGS-Based TP53 companion diagnostic based on Illumina’s genomic profiling assay.

Demand – Drivers and Limitations

The following are the drivers for the global NGS informatics market:

• The low cost of sequencing platforms is increasing public access to NGS testing, thereby improving the adoption of NGS informatics solutions.
• Increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling to identify subsequent treatment options is fueling the demand for NGS.
• A tremendous rise in the amount of genomic data is driving the adoption of NGS informatics solutions for easy analysis of data as well as for its storage and computation.
• The growing importance of population genomics studies and the establishment of various biobanks lead to extensive research throughout the world and help in advancing research and development in the genomics field.
• Advancements in big data technology will enable better storage and management of NGS data, thereby leading to more demand for NGS and higher adoption of NGS software.
• Government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.

The market is expected to face some limitations as well due to the following challenges:

• Privacy and ethical challenges are expected to lead to concerns surrounding data privacy among people, thereby hindering their participation in NGS studies.
• The lack of trained clinical personnel for conducting NGS experiments and performing data analysis is expected to hinder the adoption of NGS software.
• Poor reimbursement rates for NGS across the globe are expected to lead to a lack of interest in NGS, thereby hindering the adoption of NGS software and services.

How can this report add value to an organization?

Products and Services: The products and services segment helps the reader understand the different types of NGS informatics products and services available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the main segments, such as commercial data analysis, data interpretation and reporting tools, storage and computing tools, laboratory information management systems (LIMS), and NGS informatics services.

Growth/Marketing Strategy: The global NGS informatics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been business expansions, partnerships, and collaborations to strengthen their position in the market. For instance, in July 2021, Francisco Partners signed a definitive agreement to acquire the STARLIMS informatics product suite and related businesses.

Competitive Strategy: The key players in the global NGS informatics market analyzed and profiled in the study involve established and emerging players that offer different products for NGS informatics. Moreover, a detailed competitive benchmarking of the players operating in the global NGS informatics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent established names in this market are:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Azenta, Inc.
• BGI Genomics Co., Ltd.
• DNAnexus, Inc.
• Eagle Genomics
• Euformatics
• F. Hoffmann-La Roche Ltd.
• Genalice BV
• Illumina, Inc.
• Partek Incorporated
• PerkinElmer, Inc.
• Precigen, Inc.
• QIAGEN N.V.
• SOPHiA GENETICS SA
• Thermo Fisher Scientific Inc.

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

The post NGS Informatics Market – A Global and Regional Analysis: Focus on Products and Services, Application, End User, and Region – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The growth in the global prostate cancer testing market is expected to be driven by high investments in the field of cancer research and the rising prevalence of prostate cancer globally. In addition, the focus of business leaders is establishing a deep understanding to address the unmet needs in clinical research to understand the prostate cancer market.

Market Lifecycle Stage

The global prostate cancer testing market is in progressing phase. PSA screening or testing in a general population has increased the incidence of prostate cancer in recent decades. In addition, prostate cancer testing is essential in precision medicine because it assures the safe and successful use of tailored therapies. The majority of the companies in the global prostate cancer testing market provide biomarker tests that are urine, blood, and tissue-based, as well as testing services. Furthermore, applications of prostate cancer testing are primarily clinical and research.

Impact

One of the main reasons for the expansion of the prostate cancer testing market in the upcoming years is the rise in prostate cancer cases. Prostate cancer is the second most frequent disease diagnosed in men, and its frequency is rising across the globe. Prostate cancer is thought to be diagnosed in one million additional cases worldwide each year. Due to an aging population, growing urbanization, and accompanying lifestyle changes, the overall incidence of prostate cancer has increased over the past few decades.

Impact of COVID-19

During the coronavirus disease 2019 (COVID-19) pandemic, a number of disease models issued warnings about an excess of cancer fatalities brought on by missed cancer screenings as a result of the general population’s quarantine and a lack of healthcare resources. The COVID-19 pandemic has had a negative impact on early diagnosis in the specific case of prostate cancer, the second most common cancer in men, by reducing participation in screening programs and on time from diagnostic testing to surgery/radiotherapy, which may translate into a worse prostate-cancer-specific death rate in the coming years. Additionally, in other areas, including Florida, state governments disallowed non-essential healthcare services.

Significant reductions in cancer screenings were seen in the early stages of the COVID-19 pandemic. According to a research paper published in January 2022 by the University of Florida, screenings for prostate cancer were reduced by 74%. Due to these screening figures, there may have been thousands more cancer deaths in the U.S. than were registered.

For instance, prostate-specific antigen (PSA) testing rates and the identification of several urological malignancies, including prostate cancer, have been found to be declining in significantly afflicted populations. Several Australian urologists worry that men with possibly curable prostate cancer may have missed their chance for a cure due to low screening test uptake during the lockdowns of 2020. According to a research paper published by BMC Urology in June 2022, a total of 4,048,099 PSA tests and 118,328 prostate biopsies were performed in Australia over the six years of data analysis. In the years 2019 and 2020, 68,429 prostate magnetic resonance imaging (MRI) were performed. Between 2015 and 2019, there were, on average, 19,573 prostate biopsies and 678,082 PSA testing performed per year.

Market Segmentation:

Segmentation 1: by Test Type

• Pre-Biopsy Test
• Biopsy
• Post-Biopsy Test

Based on test type, the pre-biopsy test in the global prostate cancer testing market is expected to be dominated by the test type segment. This is due to the increasing popularity of prostate cancer testing and rising awareness related to prostate cancer testing.

Segmentation 2: by Application

• Clinical
• Research

Based on application, the global prostate cancer testing market is dominated by the clinical segment owing to the rising R&D activity focused on the development of prostate cancer testing. The diagnosis of prostate cancer has developed a new molecular-based diagnostics technology. To detect clinically relevant cancer upon diagnosis, several tools or therapeutic options are required to improve the patient’s quality of life.

Segmentation 3: by End User

• Cancer Research Institutes
• Diagnostic Laboratories
• Hospitals and Clinics
• Ambulatory Surgical Center (ASCs)
• Others

Based on end user, the global prostate cancer testing market is dominated by the ambulatory surgical centers (ASCs) segment owing to their rise in number. They are dedicated to offering same-day surgical care, including testing and protective procedures. ASCs, which have a proven track record of providing high-quality treatment and successful patient outcomes, have altered the outpatient experience for millions of Americans by giving patients a more convenient option for hospital-based outpatient operations.

Segmentation 4: by Region

• North America – U.S., and Canada
• Europe – U.K., Germany, France, Italy, Spain, Netherlands and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

North America generated the highest revenue of $2,702.9 million in 2021, which is attributed to the several established diagnostics manufacturers in this region who are focusing on expanding their portfolios in prostate cancer testing and are collaborating with service providers and pharmaceutical giants to co-market prostate cancer testing solutions with its complementary precision medicine solutions. Moreover, the U.S. government is currently undertaking several initiatives to develop tests for cancer and provide funds to new start-ups in the cancer diagnostics field.

Recent Developments in the Global Prostate Cancer Testing Market

• In September 2022, Veracyte, Inc. announced the publishing of data in the Journal of the National Cancer Institute to demonstrate the company’s decipher prostate genomic classifier may help identify African American men with early, localized prostate cancer who are most likely to harbor more aggressive disease.
• In August 2019, BioReference Laboratories, Inc. announced the selection by The IPA Association of America (TIPAAA) as its provider of laboratory services and to assist with data analytics for its members’ patients. The agreement is designed to enhance patient care and offers collaborative health management tools to TIPAAA members, which includes more than 667 medical organizations in 39 states. The members can have convenient access to BioReference’s comprehensive laboratory testing menu, including routine and specialty tests, as well as the 4Kscore for detecting aggressive prostate cancer.
• In June 2021, Thermo Fisher Scientific announced submissions open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. The grant aims to provide funding for high-quality molecular profiling studies focusing on the impact of immune-based treatments for cancer patients.

Demand – Drivers and Limitations

The following are the demand drivers for the global prostate cancer testing market:

• Rising Prevalence of Prostate Cancer Globally
• Increasing Number of Prostate Cancer Screening and Testing
• Government Initiatives Related to Prostate Cancer

The market is expected to face some limitations due to the following challenges:

• Probability of False Positive Results of Prostate Cancer Testing
• Clinical Gaps Related to Prostate Cancer Testing

How can this report add value to an organization?

Workflow/Innovation Strategy: The workflow segment helps the reader understand the two prostate cancer testing, i.e., pre-biopsy, biopsy, and post-biopsy, which further aid in diagnosis. Moreover, the study provides the reader with a detailed understanding of the different applications of prostate cancer testing in clinical and research applications.

Growth/Marketing Strategy: Prostate cancer testing is being used for both research and clinical application. Various companies are providing urine and blood, and tissue-based biomarkers that aid in the diagnosis, which is also the key strategy for market players to excel in the current prostate cancer testing market.

Competitive Strategy: Key players in the global prostate cancer testing market are analyzed and profiled in the study, including manufacturers who are involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global prostate cancer testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

• Abbott.
• Abcam plc.
• Agilent Technologies, Inc.
• Bio-Techne. (ExoDx)
• Cleveland Diagnostics, Inc.
• Danaher. (Beckman Coulter, Inc.)
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd (FOUNDATION MEDICINE, INC.)
• H.U. Group Holdings, Inc. (Fujeribio)
• mdxhealth.
• Siemens Healthcare GmbH
• Myriad Genetics, Inc.
• NeoGenomics Laboratories.
• OPKO Health, Inc. (GenPath)
• Veracyte, Inc.

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

The post Global Prostate Cancer Testing Market – A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

The global battery manufacturing equipment market is projected to reach $88,093.50 million by 2031 from $9,439.22 million in 2021, growing at a CAGR of 27.12% during the forecast period 2022-2031. China dominated the global battery manufacturing equipment market in 2021 due to the presence of a large electric vehicle industry, leading industry players across the supply chain, and a fast-developing economy.

Market Lifecycle Stage

The battery manufacturing equipment market is in the developing phase. The rising demand for batteries from electric vehicles along with increasing consumer awareness of environmental issues is leading to the development of the battery manufacturing equipment market. Batteries are springing up as a vital component in the evolution toward a more stable future due to their involvement in electrifying mobility and balancing power networks.

Impact

Some of the factors behind the expansion of the global battery manufacturing equipment market are increased usage of batteries in automotive, consumer electronics, healthcare, energy and power, etc. With the rising demand for batteries in end-use industries expanding, the battery manufacturing equipment market is also expected to grow simultaneously. Batteries are used in vehicles, storage devices, smart consumer electronics devices, human and health performance tools, defense equipment, etc. Further, the recent focus green environment is creating demand and research scientists from across the world are striving to create new production methods or battery chemistries that can employ more widely accessible, ecologically acceptable components, but these innovations are not yet extensively used.

Impact of COVID-19

The battery manufacturing equipment market declined in 2020 due to the adverse effects of the COVID-19 pandemic on the market and related businesses. The announcement of lockdown around the globe created various issues for the battery manufacturing equipment market, including cash-flow constraints, supply chain issues, a lack of trained workers, and a slump in demand from major end-use industries. End-use industries for the battery manufacturing equipment market, such as automotive, registered declined growth due to the closure of factories and supply chain disruption from 2019-2020. According to the European Automobile Manufacturer’s Association (ACEA), total sales of new vehicles in the European Union (EU) in January and February 2020 were 7.4% lower than in the same period in 2019. Moreover, surging sales of EVs after the lockdown and growing demand from the automotive, energy and power, and consumer electronics industries are expected to help the market make a swift recovery.

Market Segmentation:

Segmentation 1: by Application

• Automotive
• Consumer Electronics
• Energy and Power
• Others (Healthcare, power tools, etc.)

Based on application, the automotive segment dominated the battery manufacturing equipment market in 2021 and was the largest segment due to the rising sales of electric vehicles across the globe. Favorable governmental regulations are the dominant driver fueling growth in the adoption of the automotive Li-ion battery. Officials from a multitude of separate nations are collaborating with automobile manufacturers to seek solutions to the escalating issues of ecological sustainability and the clean energy balance.

Segmentation 2: Equipment by Process

• Electrode Manufacturing
• Cell Assembly
• Cell Finishing

Based on equipment by process, the electrode manufacturing segment held the majority share in the battery manufacturing equipment market in the year 2021 as it is the most intricate part of the process. It is the initial step in the process, and the complete value chain of the battery is dependent on it. Further, the maximum amount of energy consumption happens at this stage.

Segmentation 3: by Battery Type

• Lithium-Ion
• Lead Acid
• Nickel Cadmium
• Nickel Metal Hydride
• Others (Sodium, Carbon Zinc, Silver Oxide, etc.)

Based on battery type, the lithium-ion segment held the majority share in the battery manufacturing equipment market in 2021. Lithium-ion batteries are a preferred source of power for low-carbon technologies such as electric vehicles. Due to their quantity of energy, they can retain in a relatively small area, charging capabilities, and propensity to remain functional after hundreds, if not thousands, of charge cycles. These batteries are an essential component of the present drive to phase out gas-powered automobiles that release carbon dioxide and other carbon pollution. Furthermore, these batteries are excellent choices for power storage for the electric grid due to their similar qualities.

Segmentation 4: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Spain, Italy, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, South Korea, India, Taiwan, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World – Middle East and Africa and South America

China dominates the battery manufacturing equipment market due to the presence of a large electric vehicle industry, leading industry players across the supply chain, and a fast-developing economy. The region holds the majority of lithium-ion reserves in the world and has the potential to utilize them in various end-use industries such as automotive, consumer electronics, and others.

Recent Developments in the Global Battery Manufacturing Equipment Market

• In May 2022, by aiding customers in the U.S. with battery manufacture, Xiamen Tmax Equipments maintained a favorable connection with them. It offered them the pouch cell pilot line, which comprises 52 machines ranging from mixing to testing. In accordance with the real requirements of the customer, Xiamen Tmax Equipments supplied complete solutions for the production of coin cells, cylinder cells, pouch cells, prismatic cells, and battery packs on a lab, pilot, and large-scale.
• In June 2022, Wuxi Lead Intelligent Equipment Co., Ltd. signed a contract with Volkswagen to deliver 20GWh lithium battery manufacturing equipment. The company would strengthen its presence in the European market and mark a new era of its global operation.

Demand – Drivers and Limitations

The following are the demand drivers for the global battery manufacturing equipment market:

• Rising Demand for Electric Vehicles (EVs)
• Government Initiatives to Reduce Carbon Footprints and e-Waste

The market is expected to face some limitations too due to the following challenge:

• Rising Cost and Competitive Pressure for Battery Equipment Manufactures
• Logistics and Supply Chain Risks

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different equipment by process, and battery type available for the battery manufacturing equipment market and its potential globally. Moreover, the study gives the reader a detailed understanding of the different equipment with usage in several applications.

Growth/Marketing Strategy: Business expansion, partnership, collaboration, and joint venture are some key strategies adopted by the key players operating in the space; for instance, in September 2022, Manz AG, GROB-WERKE, and Dürr formed a unique European alliance in the realm of lithium-ion battery production technology.

Competitive Strategy: Key players in the battery manufacturing equipment market are analyzed and profiled in the study involving battery manufacturing equipment manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the battery manufacturing equipment market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Wuxi Lead Intelligent Equipment Co., Ltd.
• SHENZHEN YINGHE TECHNOLOGY CO., LTD.
• Targray
• Xiamen Tmax Equipments
• DAIICHI JITSUGYO CO., LTD. (DJA)
• SOVEMA GROUP S.p.A.
• Battery Technology Source Co. Ltd. (BTS)
• Hitachi High-Tech Corporation
• CKD
• Manz AG
• Wirtz Manufacturing
• Buhler
• HIRANO TECSEED Co., Ltd
• Foshan Golden Milky Way Intelligent Equipment Co., Ltd. (GMK)
• Readco Kurimoto, LLC
• Lyric
• Shanghai Putailai New Energy Technology Co., Ltd.
• Super Components

The post Battery Manufacturing Equipment Market – A Global and Regional Analysis: Focus on Application, Equipment by Process, Battery Type, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The global next-generation lithography materials market is projected to reach $1,005.3 million by 2031 from $85.7 million in 2021, growing at a CAGR of 29.46% during the forecast period 2022-2031.

The next-generation lithography materials market is expected to grow at a healthy growth rate, owing to the growing demand for cutting-edge microchips and semiconductors in smartphones and wearable technology. According to International Data Corporation, smartphone shipments increased by 7.7% in 2021 compared to 2020. Smartphone players are implementing several technologies to reduce the weight and increase the features of smartphones to gain a strong foothold in the industry, creating a demand for next-generation lithography materials and technologies.

In addition, technological advancements, and increased investment in nanotechnology and nanodevices are driving the demand for nanolithography by creating a need for making structures on the nanometre scale, which in turn is complementing next-generation lithography materials’ demand. Furthermore, the U.S. government is making effective investments in nanotechnology through the National Nanotechnology Initiative (NNI), a U.S. government R&D initiative that brings together federal departments and agencies with interests in nanomaterials research, development, and commercialization. Therefore, the aforementioned factors complement the NGL materials market growth.

Market Lifecycle Stage

Next-generation lithography is a process that transfers patterns from a photomask to a photoresist (light-sensitive chemical) on a substrate using light sources with wavelengths less than 193nm. The photoresist is either inherently sensitive to radiation or is formulated with a photosensitive compound that produces a reactive species when exposed to light. Extreme ultraviolet lithography (EUVL), which uses a wavelength of 13.5 nm, is currently the most widely used next-generation lithography technique. Other next-generation lithography techniques include electron beam lithography, nanoimprint lithography, focused ion beam lithography, x-ray lithography, and others.

Next-generation lithography technologies are gaining popularity. However, the high cost of next-generation lithography scanners and materials is a major barrier to its widespread adoption in several countries. Currently, Advanced Semiconductor Materials Lithography (ASML) is the only company providing EUV lithography machinery. However, with additional players entering the ecosystem in the coming years, the next-generation lithography materials industry is expected to expand significantly.

Impact

With a greater global emphasis on digital technologies such as 5G networks, artificial intelligence, and IoT, the shift to miniaturization of devices and enhancement of features opens significant sales and financing opportunities. This shift was prominently experienced in regions such as North America, Europe, and some Asian countries.

Impact of COVID-19

In 2020, the global lockdown caused by COVID-19 epidemic caused disruptions in manufacturing activity and supply networks, as well as production halts. However, due to changing consumer habits fuelled by the rise in remote work and distance learning, the demand for semiconductors increased. As a result of this, semiconductor fabricators resumed production lines, with ease in lowdown restriction, to meet the growing demand for chips used in consumer electronics such as laptops, tablets, and smartphones. Furthermore, as digitization expands into every facet of daily life, demand for semiconductors continues to surge far beyond the global capacity for supply. This creates a need for expanding production and improving features of semiconductors, thus influencing advanced semiconductor materials demand including next generation lithography materials.

Market Segmentation:

Segmentation 1: by Application

• Automotive
• Consumer Electronics
• IT & Telecommunications
• Others

In 2021, the consumer electronics sector segment dominated the overall next-generation lithography materials market in terms of value and volume, and it is expected to continue dominating the market till 2031.

Segmentation 2: by Material

• Photoresist Material
• Ancillary Material

The global next-generation lithography materials market is estimated to be led by photoresist material.

Segmentation 3: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Sweden, Spain, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, South Korea, Taiwan, India and Rest-of-Asia-Pacific
• Rest-of-the-World

Asia Pacific and Japan led the next-generation lithography materials market in 2021 and is anticipated to uphold its dominance throughout the forecast period (2022-2031), owing to the presence of significant semiconductor players such as Taiwan Semiconductor Manufacturing Company Limited (TSMC), Samsung Electronics Co., Ltd.

Recent Developments in the Global Next-Generation Lithography Materials Market

• In August 2022, JSR Corporation signed an investment agreement with the Lingang Special Area Government to establish a subsidiary in Shanghai. This is expected to expand JSR Group’s business activities in the Chinese market relating to semiconductor materials. It is tentatively scheduled to begin operations in December 2022.

• In January 2021, Industrial Technology Research Institute (ITRI) and DuPont de Nemours, Inc. established a semiconductor materials laboratory in Hsinchu, Taiwan. DuPont is expected to conduct semiconductor material research, development, and enhancement in collaboration with ITRI, as well as accelerate pilot testing and commercial viability to support DuPont’s customers as they seek the next generation of semiconductors in Taiwan.

• In October 2020, Shin-Etsu Chemical Co., Ltd. invested around $278 million (¥30 billion) in photoresist manufacturing facilities in Japan and Taiwan. Shin-Etsu is expected to continue making facility investments to meet the rising demand for photoresists, which are critical in cutting-edge semiconductor manufacturing, as well as technological advancements.

Demand – Drivers and Limitations

Following are the demand drivers for the next-generation lithography materials market:

• Rising Proliferation of Feature Phones, and Tablets
• Increasing R&D Activities on Next-Generation Lithography Materials

The market is expected to face some limitations due to the following challenges:

• High Cost of Raw Materials
• Limited Number of Players Offering Next-Generation Lithography Machinery

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the technology used in manufacturing next-generation lithography materials, including photoresist and ancillary material. Moreover, the study provides the reader with a detailed understanding of the next-generation lithography materials market by different application sectors (automotive, consumer electronics, IT & telecommunications, and others).

Growth/Marketing Strategy: The global next-generation lithography materials market has seen development by key players operating in the market, such as product launches, business expansion, partnership, collaboration, acquisition, and joint venture. The favored strategy for the companies has been expansion and collaboration to strengthen their position in the next-generation lithography materials market.

For instance, in February 2021, JSR Corporation joined Inpria Corporation’s Series C funding round to support the company’s initiatives for commercializing EUV (Extreme Ultraviolet) photoresists.

Competitive Strategy: Key players in the global next-generation lithography materials market analyzed and profiled in the study involve next-generation lithography materials manufacturers and the overall ecosystem. Moreover, a detailed competitive benchmarking of the players operating in the global next-generation lithography materials market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

• Tokyo Ohka Kogyo Co., Ltd (TOK)
• JSR Corporation
• DuPont de Nemours, Inc.
• Shin-Etsu Chemical Co., Ltd
• Fujifilm Corporation.
• Sumitomo Chemical Co., Ltd.
• Allresist GmbH
• micro resist technology GmbH
• Merck KGaA
• Dongjin Semichem Co. Ltd.
• Brewer Science, Inc.
• SACHEM, INC.
• Kayaku Advanced Materials, Inc.
• Avantor Performance Materials Inc.
• Irresistible Materials Ltd
• Weifang Startech Microelectronic Materials Co., Ltd.
• KemLab Inc.
• Jiangsu Nanda Photoelectric Materials Co., Ltd
• Shenzhen Didao Microelectronics Technology Co., Ltd

The post Next-Generation Lithography Materials Market – A Global and Regional Analysis: Focus on Application, Material, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The global satellite docking system market is estimated to reach $1,011.34 million in 2032 from $40.3 million in 2021, at a growth rate of 31.3% during the forecast period 2022-2032. The growth in the global satellite docking system market is expected to be driven by the enforcement of regulations on space sustainability and increase in in-orbit services.

Market Lifecycle Stage

Over the past few years, trends in the number of satellites launched by commercial satellite operators have been increasing drastically. The global satellite launch forecast estimates 45,131 satellites to be launched within the 2022-2032 timeline.

Out of these 45,131 satellites, 95% of satellites are expected to operate in low Earth orbit (LEO). This indicates that over 95% of the satellites are expected to operate in one orbital segment leading to a growing state of congestion, which further adds to the risk perception of collision and space debris concerns.

In addition, commercial satellite operators are opting for the life extension program to keep their existing satellites alive in space for longer periods. This will help them to reduce the satellite operation cost and increase their revenue with the existing satellite.

Furthermore, it helps to remove the active space debris to keep the space debris-free and sustainable and reduce the risk of collision. Given the circumstance, the need for a satellite docking system is very high at this point, and the same is expected to persist as well.

Impact

The global satellite docking system market is observing rising investment across all the satellite platforms, which drives the investments across the docking system technology. The major challenge in developing the satellite docking system is there is no standardization in design and mechanism among the satellite docking manufacturers.

This leads the developer to integrate their own satellite docking system in their in-orbit service vehicle, which will create incompatibility with the docking system that is integrated with the target satellites.

In addition, different small satellite operators are building different types of satellites. Although many satellites use standardized satellite platforms, they are customized products with unique configurations. Therefore, their docking solution requirement will also vary from operator to operator. This will create a need for a variety of satellite docking solutions both for target satellites and service satellites.

Market Segmentation

Segmentation 1: by Service Type

• Refueling
• Inspection, Repair, and Replacement
• De-Orbiting

Based on service type, the satellite docking system market is expected to be dominated by the refueling service satellite during the forecast period.

Segmentation 2: by End User

• Commercial
• Civil Government
• Military
• Deep Space

Based on end user, the global satellite docking system market is expected to be dominated by commercial end users.

Segmentation 3: by Spacecraft Type

• Target Satellites
• Service Satellites

Segmentation 4: by Region

• North America
• Europe
• Rest-of-the-World

North America is expected to account for the highest share of 78% in the satellite docking system market by value in 2021, owing to a significant number of companies based in the region.

Recent Developments in the Global Satellite Docking System Market

• In November 2022, Starfish Space announced that its Otter Pup satellite with high-performance low-thrust electric propulsion, which includes a satellite docking system, is planned to launch in the spring of 2023 to dock with another satellite in the fall of 2023.

• In October 2022, High Earth Orbit (HEO) Robotics collaborated with Satellogic to integrate Satellogic’s growing satellite constellation and high-resolution satellite imagery with HEO’s flyby inspection and computer-vision capabilities.

• In September 2022, Astroscale Holdings, Inc. received funding of $1.79 million from the U.K. Space Agency to develop technologies and capabilities for Cleaning Outer Space Mission through Innovative Capture, which consists of Astroscale’s robotic debris capture capabilities and rendezvous and proximity operations to remove space debris and defunct satellites.

• In May 2022, Momentus Inc. signed a partnership with SpaceX for the integration of its Vigoride Orbital Transfer Vehicle and customer payloads on Falcon 9, which would be used for the transporter-5 mission.

• In April 2022, Lockheed Martin Corporation released an open-source Augmentation System Port Interface (ASPIN), a non-proprietary interface standard to support on-orbit servicing and mission augmentation. It uses Mission Augmentation Port (MAP) interface standard online that provides a mechanical interface design for docking spacecraft to one another.

• In March 2022, Rogue Space Systems Corporation announced that Seldor Capital is their first institutional investor, which helps the company to scale up its engineering and operations teams.

• In November 2021, Astroscale Holdings, Inc. launched a universal docking device for spacecraft, “Docking Plate,” to capture and de-orbit the defunct satellite.

• In September 2021, Starfish Space secured an investment of about $7 million from NFX and MaC Venture Capital along with PSL Ventures, Boost VC, Liquid2 Ventures, and Hypothesis.

• In September 2021, Orbit Fab, Inc. launched its first propellant tanker to geostationary orbit, which has been designed for refueling the largest space assets and for the harshest orbital regimes.

Demand – Drivers and Limitations

Following are the drivers for the global satellite docking system market:

• Growing Demand for Sustainable Space Operations
• Growing Demand for Optimizing Satellite Operation Cost

Following are the challenges for the global satellite docking system market:

• Lack of Industry Wide Standardization of Docking Solutions
• Reduction in Manufacturing and Launch Costs Impacting the Financial Viability of In-Orbit Services

Following are the opportunities for the global satellite docking system market:

• Opportunity for Software Solution for Rendezvous/Proximity Operations
• Evolution of Standardized Satellite Platform
• Enabling Capabilities for Rendezvous/Proximity Operations

How can this report add value to an organization?

Platform/Innovation Strategy: The product segment helps the reader understand the different types of spacecraft and their related docking components in the industry to conduct safe and secure in-orbit services and life extension missions. Moreover, the study provides the reader with a detailed understanding of the different spacecraft by service satellites and target satellites. In addition, it provides a detailed understanding of the different components used in both the satellites, such as docking plate, refueling port, robotic arm, onboard computer, electromagnet attachment mechanism, rotational alignment guides, sensor unit, and other interfaces.

Growth/Marketing Strategy: The global satellite docking system market has seen major development activities by key players operating in the market, such as business expansion activities, contracts, mergers, partnerships, collaborations, and joint ventures. The favored strategy for the companies has been contracts to strengthen their position in the satellite docking system market. For instance, in September 2022, ClearSpace signed a contract with the U.K. Space Agency of about $2.32 million to perform a feasibility study for a mission to remove derelict objects from low Earth orbit (LEO). Furthermore, in May 2022, Starfish Space collaborated with Benchmark Space Systems to develop advanced precision on-orbit refueling and docking capabilities. To optimize spacecraft control accuracy, Starfish is integrating and testing its CEPHALOPOD RPOD software with Benchmark’s non-toxic hydrogen peroxide-fueled Halcyon thruster for manoeuvres.

Competitive Strategy: Key players in the global satellite docking system market analyzed and profiled in the study involve satellite docking system manufacturers that offer docking systems and enabling capabilities. Moreover, a detailed competitive benchmarking of the players operating in the global satellite docking system market offers various solutions to satellites in space through in-orbit refueling, remove active space debris, inspect, repair, and replace the defect devices. Additionally, comprehensive competitive strategies such as contracts, partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysis of the company’s coverage, product portfolio, and market penetration.

Some prominent established names in this market are:

Company Type 1: Satellite Docking System Supplier

• Altius Space Machines, Inc.
• Astroscale Holdings, Inc.
• ClearSpace
• Lockheed Martin Corporation
• Northrop Grumman
• Orbit Fab, Inc.
• QinetiQ
• Rogue Space Systems Corporation
• Starfish Space

Company Type 2: Enabling Solution Providers

• D-Orbit SpA
• High Earth Orbit Robotics
• LMO
• Maxar Technologies
• Momentus Inc.
• Obruta Space Solutions Corp.
• Orbit Recycling
• Tethers Unlimited, Inc.

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Related reports:

• Satellite-Based Cloud Computing Market – A Global and Regional Analysis: Focus on End User, Application, Product, and Country – Analysis and Forecast, 2022-2032
• Satellite Electric Propulsion Market – A Global and Regional Analysis: Focus on Mass Class, Mission Type, Mission Application, Component, and Country – Analysis and Forecast, 2022-2032
• Satellite Commercial-Off-the-Shelf Components Market – A Global and Regional Analysis: Focus on Mass Class, Subsystem, and Country – Analysis and Forecast, 2022-2032
• Impact of COVID-19 on Food & Agriculture Technology and Products Market : Segmented By: Industry (Animal, Agriculture, Cold Chain, Food & Beverage, and Cannabis), By Technology (Cold Chain Technology, Food & Beverages GPS Technology, Satellite Imaging Technology, Others), And Region – Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031
• Satellite Communication (Satcom) Market: Segmented: by solution (Products and Services): by platform (Portable, Land Mobile, Land Fixed, Airborne, and Maritime), And Region 鈥?Global Analysis Of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031
• Global Small Launch Vehicle (SLV) Market – A Comprehensive Launch Market Assessment: Focus on End User, Satellite Mass, Platform Type, Propulsion Type, Service Type, and Country – Analysis and Forecast, 2022-2032 Satellite Bus Market Research Report – Forecast till 2027
• Satellite Earth Observation Market – A Global and Regional Analysis: Focus on End User, Application, Services, Manufacturing, Technology, Altitude, and Country – Analysis and Forecast, 2022-2032
• Global Optical Satellite Communication Market Analysis and Forecast Report 2030 Satellite PNT Technology Market (Position, Navigation, and Timing Technology Market ) – A Global and Regional Analysis: Focus on Application, End User, Component, and Country – Analysis and Forecast, 2021-2031

The post Satellite Docking System Market – A Global and Regional Analysis: Focus on Service Type, End User, Spacecraft Type, and Country – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

Market Overview

The demand for ready-mix concrete is growing significantly in the European market owing to the growth of the construction industry and rising awareness about the benefits of ready-mix concrete.
The Europe ready-mix concrete market is projected to grow at 4.0% CAGR during the forecast period, 2021–2027. In 2020, the Europe ready-mix concrete market was dominated by Germany with a 25.7% share, followed by France and the UK with shares of 17.7% and 11.4%, respectively.
Ready-mix concrete is concrete that is manufactured in a batch plant, according to each specific job requirement. It is then delivered to the job site “ready to use” in construction and renovation applications. The Europe ready-mix concrete market is rapidly growing due to the growing construction industry and rising awareness about the benefits of ready-mix concrete. However, the market’s growth is likely to be hampered by the fluctuating cost of construction materials. On the other hand, the adoption of ready-mix concrete in green construction for sustainable development is expected to present a growth opportunity for the market players.

Market Segmentation

The Europe ready-mix concrete market has been segmented based on product, production, application, and country. Based on product, the Europe ready-mix concrete market has been segmented into transit mixed concrete, shrink mixed concrete and central mixed concrete. The transit mixed concrete segment is expected to grow at 4.4% during the forecast period. In 2020, the transit mixed concrete segment held a share of 49% of the Europe ready-mix concrete market.
Based on production, the Europe ready-mix concrete market has been segmented into on-site and off-site. The on-site segment is expected to grow at 4.3% during the forecast period. In 2020, the on-site segment held a 58.8% share of the Europe ready-mix concrete market.
Based on application, the Europe ready-mix concrete market has been segmented into residential, commercial, industrial, and infrastructure. The industrial segment is expected to grow at 3.3% during the forecast period. In 2020, the industrial segment held a 36.8% share of the Europe ready-mix concrete market.

Regional Analysis

Based on region, the report on the Europe ready-mix concrete market has been segmented into Germany, the UK, Italy, Spain, France, Belgium, and the Rest of Europe.
Germany is Europe’s leading construction market and home to the continent’s largest building supply. The continuous boom in German construction investment is largely expected to increase the demand for ready-mix concrete in the foreseeable future. In 2020, the transit mixed concrete segment accounted for the largest share 2020 with a market value of USD 1,630.2 million on the basis of Products, in the UK ready-mix concrete market.

In 2020, the transit mixed concrete segment accounted for the largest share 2020 with a market value of USD 1,630.2 million based on Products, in the UK ready-mix concrete market.

Major Players

VICAT, LafargeHolcim Ltd, Buzzi Unicem, CEMEX S.A.B. de C.V., HEIDELBERGCEMENT AG, FLSmidth are some of the key players operating in the market.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1 EUROPE READY-MIX CONCRETE MARKET, BY PRODUCT
1.2 EUROPE READY-MIX CONCRETE MARKET, BY PRODUCTION
1.3 EUROPE READY-MIX CONCRETE MARKET, BY APPLICATION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 GROWTH OF THE CONSTRUCTION INDUSTRY
4.2.2 RISING AWARENESS ABOUT THE BENEFITS OF READY-MIX CONCRETE
4.2.3 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 FLUCTUATING COST OF CONSTRUCTION MATERIALS
4.3.2 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 ADOPTION OF READY-MIX CONCRETE IN GREEN CONSTRUCTION FOR SUSTAINABLE DEVELOPMENT
4.5 COVID-19 IMPACT ANALYSIS
4.5.1 ECONOMIC IMPACT
4.5.1.1 IMPACT ON THE CONSTRUCTION INDUSTRY
4.5.2 IMPACT ON PRODUCTION
4.5.3 IMPACT ON READY-MIX CONCRETE INDUSTRY
4.5.3.1 IMPACT ON SUPPLY CHAIN
4.5.3.2 IMPACT ON RAW MATERIALS
4.5.3.3 CASH FLOW CONSTRAINTS
4.5.4 IMPACT ON WORLD TRADE
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 RESEARCH & DEVELOPMENT
5.1.2 RAW MATERIAL SUPPLY
5.1.3 MANUFACTURING
5.1.4 SALES & DISTRIBUTION
5.1.5 END USERS
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 REGULATORY FRAMEWORK
5.3.1 EUROPEAN COMMISSION
5.3.1.1 REGULATION (EU) NO 305/2011 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
5.3.1.1.1 THIS REGULATION SHOULD NOT AFFECT THE RIGHT OF MEMBER STATES TO SPECIFY THE REQUIREMENTS THEY DEEM NECESSARY TO ENSURE THE PROTECTION OF HEALTH, THE ENVIRONMENT AND WORKERS WHEN USING CONSTRUCTION PRODUCTS.
5.3.1.1.2 COUNCIL DIRECTIVE 89/106/EEC OF 21 DECEMBER 1988 ON THE APPROXIMATION OF LAWS, REGULATIONS AND ADMINISTRATIVE PROVISIONS OF THE MEMBER STATES RELATING TO CONSTRUCTION PRODUCTS (3) AIMED TO REMOVE TECHNICAL BARRIERS TO TRADE IN THE FIELD OF CONSTRUCTION PRODUCTS IN ORDER TO ENHANCE THEIR FREE MOVEMENT IN THE INTERNAL MARKET.
5.3.1.1.3 IN ORDER TO ALLOW A MANUFACTURER OF A CONSTRUCTION PRODUCT TO DRAW UP A DECLARATION OF PERFORMANCE FOR A CONSTRUCTION PRODUCT WHICH IS NOT COVERED OR NOT FULLY COVERED BY A HARMONISED STANDARD, IT IS NECESSARY TO PROVIDE FOR A EUROPEAN TECHNICAL ASSESSMENT.
5.3.1.1.4 MANUFACTURERS OF CONSTRUCTION PRODUCTS SHOULD BE ALLOWED TO REQUEST EUROPEAN TECHNICAL ASSESSMENTS TO BE ISSUED FOR THEIR PRODUCTS ON THE BASIS OF THE GUIDELINES FOR EUROPEAN TECHNICAL APPROVAL ESTABLISHED UNDER DIRECTIVE 89/106/EEC. THE RIGHT TO USE THOSE GUIDELINES AS EUROPEAN ASSESSMENT DOCUMENTS SHOULD THEREFORE BE ENSURED.
5.3.2 HELLENIC CEMENT INDUSTRY ASSOCIATION
5.3.2.1 CONCRETE STANDARDS
5.3.2.2 READY MIX CONCRETE: PRODUCTION –QUALITY CONTROL
6 EUROPE READY-MIX CONCRETE MARKET, BY PRODUCT
6.1 OVERVIEW
6.1.1 TRANSIT MIXED CONCRETE
6.1.2 SHRINK MIXED CONCRETE
6.1.3 CENTRAL MIXED CONCRETE
7 EUROPE READY-MIX CONCRETE MARKET, BY PRODUCTION
7.1 OVERVIEW
7.1.1 ON-SITE
7.1.2 OFF-SITE
8 EUROPE READY-MIX CONCRETE MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 RESIDENTIAL
8.1.2 COMMERCIAL
8.1.3 INDUSTRIAL
8.1.4 INFRASTRUCTURE
9 EUROPE READY-MIX CONCRETE MARKET, BY REGION
9.1 OVERVIEW
9.1.1 GERMANY
9.1.2 FRANCE
9.1.3 UK
9.1.4 SPAIN
9.1.5 ITALY
9.1.6 BELGIUM
9.1.7 REST OF EUROPE
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MARKET SHARE ANALYSIS
10.4 KEY DEVELOPMENTS IN THE EUROPE READY-MIX CONCRETE MARKET
10.4.1 MERGER & ACQUISITION
10.4.2 PRODUCT LAUNCH
10.4.3 PARTNERSHIP
10.4.4 EXPANSION
10.4.5 COLLABORATION
11 COMPANY PROFILES
11.1 VICAT
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 LAFARGEHOLCIM LTD
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 BUZZI UNICEM
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 CEMEX S.A.B. DE C.V.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 HEIDELBERGCEMENT AG.
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 FLSMIDTH
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 ELKON
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 CRH
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 CEMENTIR HOLDING N.V.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES

The post Europe Ready-Mix Concrete Market Research Report Forecast to 2027 first appeared on CRI Report.